N-Nitroso Oxetacaine Stage D | N-methyl-N-(2-methyl-1-phenylpropan-2-yl)nitrous amide
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.N-Nitroso Oxetacaine Stage D can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Nitrosamines .N-Nitroso Oxetacaine Stage D is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Oxetacaine Stage D CAS NO: NA Chemically represented as N-methyl-N-(2-methyl-1-phenylpropan-2-yl)nitrous amide.Synchemia is the leading manufacturing and exporter of N-Nitroso Oxetacaine Stage D .We supply N-Nitroso Oxetacaine Stage D with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142354 |
| CAS No | NA |
| Mol.F. | C58H72N8O18 |
| Mol.Wt. | 1169.25 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142355 |
| CAS No | NA |
| Mol.F. | C14H18N2O3 |
| Mol.Wt. | 262.31 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142356 |
| CAS No | NA |
| Mol.F. | C12H14N2O5 |
| Mol.Wt. | 266.25 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142357 |
| CAS No | NA |
| Mol.F. | C13H15N3O4 |
| Mol.Wt. | 277.28 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142358 |
| CAS No | NA |
| Mol.F. | C14H16FN3O4 |
| Mol.Wt. | 309.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142359 |
| CAS No | NA |
| Mol.F. | C16H18N2O3 |
| Mol.Wt. | 286.33 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142360 |
| CAS No | NA |
| Mol.F. | C16H14N2O3 |
| Mol.Wt. | 282.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142361 |
| CAS No | NA |
| Mol.F. | C16H10N2O4 |
| Mol.Wt. | 294.27 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142362 |
| CAS No | NA |
| Mol.F. | C17H16N2O3 |
| Mol.Wt. | 296.33 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142363 |
| CAS No | NA |
| Mol.F. | C33H30N4O5 |
| Mol.Wt. | 562.63 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142364 |
| CAS No | NA |
| Mol.F. | C16H14N2O6S |
| Mol.Wt. | 362.36 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142365 |
| CAS No | NA |
| Mol.F. | C16H14N2O6S |
| Mol.Wt. | 362.36 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142366 |
| CAS No | NA |
| Mol.F. | C20H15F7N2O4 |
| Mol.Wt. | 480.34 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142367 |
| CAS No | NA |
| Mol.F. | C23H20F7N5O4 |
| Mol.Wt. | 563.43 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142368 |
| CAS No | NA |
| Mol.F. | C24H24F7N5O5 |
| Mol.Wt. | 595.47 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142369 |
| CAS No | NA |
| Mol.F. | C4H7ClN4O3 |
| Mol.Wt. | 194.58 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |